Photo of Brandon Hayes-Lattin, M.D.

Brandon Hayes-Lattin M.D.

Dr. Brandon Hayes-Lattinserves as Professor of Medicine and Medical Director in the Division of Hematology and Medical Oncology at Oregon Health and Science University, and Medical Director of the OHSU Knight Cancer Institute’s Adolescent and Young Adult (AYA) Oncology Program. His clinical background is in the management of hematologic malignancies and the use of hematopoietic stem cell transplantation. As a young adult cancer survivor himself, and a physician caring for many young adults with hematologic malignancies, Dr. Hayes-Lattin has taken a leadership role in the development of the discipline of AYA Oncology. He has served as the Senior Medical Advisor to the LIVESTRONG Foundation, the Chief Medical Officer for Critical Mass: The Young Adult Cancer Alliance, the inaugural Chair of the AYA Committee for SWOG, participated on the expert advisory panel to the Children’s Oncology Group AYA Committee, and was a member of the CDC’s Federal Advisory Committee on Breast Cancer in Young Women.


  • B.S., Stanford University 1992
  • M.D., University of Washington, 0 1997
  • Residency:

    • Oregon Health & Science University, 2000
  • Fellowship:

    • Adult bone marrow transplant, Oregon Health & Science University, 2001

Honors and awards

  • Oncology Professional Award, The Ulman Cancer Fund for Young Adults
  • Faculty Award, The OHSU Student Council
  • Teaching Certificate of Appreciation, Division of Physician Assistant Education
  • Medical House Staff Teaching Award
  • John S. Miller Award for Outstanding Teaching

Memberships and associations

  • American Society of Hematology
  • American Society of Clinical Oncology
  • Fellow, American College of Physicians
  • American Society for Blood and Marrow Transplantation


  • "Hematopoietic Cell Transplantation in Germ Cell Tumors"  March 5 2009
  • "Survivors of childhood cancer [9]" New England Journal of Medicine January 11 2007
  • "The relationship between posttraumatic stress and posttraumatic growth among adolescent and young adult (AYA) cancer patients" Psycho-Oncology  2015
  • "Starting an Adolescent and Young Adult Program" Journal of Clinical Oncology November 10 2010
  • "If you did not document it, it did not happen" Journal of Oncology Practice March 1 2015
  • "Molecular analysis and polymorphism of the DLA-DQB genes" HLA  1998
  • "Prevalence and predictors of post-traumatic stress symptoms in adolescent and young adult cancer survivors" Psycho-Oncology August 2013
  • "Improved outcome with busulfan, melphalan and thiotepa conditioning in autologous hematopoietic stem cell transplant for relapsed/refractory Hodgkin lymphoma" Leukemia and Lymphoma March 2014
  • "Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery" Journal of Clinical Oncology February 1 2010
  • "Second Autologous Stem Cell Transplantation for Relapsed Lymphoma after a Prior Autologous Transplant" Biology of Blood and Marrow Transplantation August 2008
  • "Improving enrollment in clinical trials for adolescents with cancer" Pediatrics June 1 2014
  • "Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients" Bone Marrow Transplantation August 2013
  • "Isolation in the allogeneic transplant environment" Bone Marrow Transplantation September 2005
  • "Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery" Journal of Urology October 2010
  • "Allogeneic stem-cell transplantation in renal-cell carcinoma." Current Oncology Reports September 2001
  • "Psychological distress and unsatisfied need for psychosocial support in adolescent and young adult cancer patients during the first year following diagnosis" Psycho-Oncology November 1 2014
  • "A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma" Biology of Blood and Marrow Transplantation January 2010
  • "Testicular Cancer" Seminars in Oncology October 2009
  • "Toxic megacolon" Bone Marrow Transplantation September 2002
  • "Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever (Antimicrobial Agents and Chemotherapy (2009) 53, 2, (428-434))" Antimicrobial Agents and Chemotherapy July 2009
  • "Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100)" Bone Marrow Transplantation  2009
  • "Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever" Antimicrobial Agents and Chemotherapy February 2009
  • "Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia" Biology of Blood and Marrow Transplantation December 2012
  • "Survivorship"   2011
  • "Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer" Journal of the National Cancer Institute April 20 2011
  • "Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors" Annals of Oncology October 29 2009
  • "Psychosocial service use and unmet need among recently diagnosed adolescent and young adult cancer patients" Cancer January 1 2013
  • "Outcomes of Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adults Compared with Children and Older Adults with Acute Myeloid Leukemia" Biology of Blood and Marrow Transplantation June 2012
  • "Evolution in management of testicular seminoma" Annals of Oncology  2011
  • "Successful treatment of metastatic hormone-refractory prostate cancer with malignant pericardial tamponade using docetaxel" Urology  2002

Additional information

Edit profile